We have 3 of 56 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
The results indicate that ASFV‐Δ24 can be used as an effective and promising candidate vaccine to control the spread of ASFV.
This study aimed to characterize the mutational and evolutionary patterns of the SVA genome during its transmission within host cells exhibiting enhanced innate immunity, and indicated that the mutant virus was unable to evade host antiviral innate immunity, whereas it significantly enhanced the translational activity...
The MGF100 family is a potential multigene-deleted target for ASFV live-attenuated vaccine development and was found to be capable of inducing a robust innate immune response in vitro and a consistent P30 antibody response in vivo.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
